EUVIMED · CrossrefZeitschrift
Psychopharmacology Bulletin
ISSN 0048-5764 · MedWorks Media
Neueste Artikel
Bupropion-Induced Aseptic Meningitis: Postmarketing Safety Evaluation and Case Report
Clinical Course and Discontinuation of Olanzapine Long-Acting Injectable: A Retrospective Case Series Including a Case of Post-Injection Delirium/Sedation Syndrome
Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research
Psychopharmacologic and Behavioral Interventions in Inducible Laryngeal Obstruction: A Psychosomatic Interface Between Psychiatry and Pulmonary Medicine
Psycho Social Challenges and Problems Faced by Elderly People in North Kerala—A Comprehensive Study
Non-Hormonal Psychopharmacotherapy of Vasomotor Symptoms Related to Menopause
Psychopharmacotherapy of Eating Disorders—
Psychobiotics: A Paradigm Shift in Dermatological Disorders
Consideration of Mood Temperaments and Subthreshold Affective States in Opiate Use Disorder—A Primer
Unmasking Panic Disorder in Adults with Leukemia: A Systematic Review of Prevalence, Risk Factors, and Management
Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson’s Disease Using the Food and Drug Administration Adverse Event Reporting System
Genetic Polymorphisms and Hemostatic-Inflammatory Biomarkers in Schizophrenia Patients Receiving Antipsychotic Treatment
Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary
Lurasidone Induced Amphibian Like Buccal Oscillations: A Rare Case of Early Onset Tardive Dyskinesia Like Disorder in a Geriatric Patient with Treatment-Resistant Depression
Anti-N-Methyl-D-Aspartate Receptor Encephalitis Presenting as Acute Psychosis in a Renal Transplant Recipient Under Chronic Immunosuppression
Bridging Nonconsecutive Esketamine Weeks with Bupropion and Over-the-Counter Dextromethorphan
Opioid Withdrawal Following Intrathecal Morphine Pump Explantation Managed with a Structured Oral Opioid Taper: A Case Study
EUVIMED